MEI Pharma Inc. has announced a private placement agreement to raise approximately $100 million through the sale of 29,239,767 shares of common stock at $3.42 per share. The proceeds will be dedicated to implementing a Litecoin Treasury Strategy, marking MEI Pharma as the first publicly traded company on a national exchange to hold Litecoin. Charlie Lee, the founder of Litecoin and a lead investor in the transaction, will join MEI's Board of Directors upon closing, replacing current member Taheer Datoo. GSR will oversee the company's digital asset and treasury management. Titan Partners Group is acting as the sole placement agent for this transaction, which is expected to close around July 22, 2025, pending customary closing conditions.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。